Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: A modelling study.

Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: A modelling study.

Evidence on the economic impact of novel skin tests for tuberculosis infection (TBST) is scarce and limited by study quality. We used estimates on the cost-effectiveness of the use of TBST compared to current tuberculosis infection (TBI) tests to assess whether TBST are affordable and feasible to im...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lara Goscé, Kasim Allel, Yohhei Hamada, Alexei Korobitsyn, Nazir Ismail, Saima Bashir, Claudia M Denkinger, Ibrahim Abubakar, Peter J White, Molebogeng X Rangaka
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLOS Global Public Health
Online Access:	https://doi.org/10.1371/journal.pgph.0002573
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays.
by: Lara Goscé, et al.
Published: (2024-01-01)

Cost-effectiveness of diagnostic technologies for mycobacterium tuberculosis infection in India and Brazil.
by: Saima Bashir, et al.
Published: (2024-01-01)

Concurrent use of low complexity automated NAATs for TB diagnosis and detection of resistance: A cost-effectiveness analysis.
by: Suvesh Kumar Shrestha, et al.
Published: (2025-01-01)

Concurrent use of low complexity automated NAATs for TB diagnosis and detection of resistance: A cost-effectiveness analysis
by: Suvesh Kumar Shrestha, et al.
Published: (2025-01-01)

Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol
by: Marc Lipman, et al.
Published: (2021-12-01)

WHO target product profile for TB detection at peripheral settings: 2024 update
by: Mikashmi Kohli, et al.
Published: (2025-01-01)

Community and Universal Testing for TB among close contacts of microbiologically confirmed pulmonary TB patients in two high TB burden countries: a protocol for a pragmatic cluster-randomised control trial
by: Mgcini Moyo, et al.
Published: (2025-08-01)

TB antigen-based skin tests and QFT-Plus for Mycobacterium tuberculosis infection diagnosis in Brazilian healthcare workers: a cost-effectiveness analysis
by: Fernanda Mattos de Souza, et al.
Published: (2025-02-01)

Costs and cost-effectiveness of integrated screening for non-communicable diseases in TB contacts
by: Y. Hamada, et al.
Published: (2025-03-01)

Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.
by: Gyaviira Nkurunungi, et al.
Published: (2012-01-01)

END TB – THE NEW WHO STRATEGY IN THE SDG ERA* , AND THE CONTRIBUTIONS FROM THE RUSSIAN FEDERATION
by: M. C. Raviglione, et al.
Published: (2016-11-01)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
by: Owen Leddy, et al.
Published: (2023-04-01)

Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome.
by: Keira H Skolimowska, et al.
Published: (2012-01-01)

Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.
by: Jayne S Sutherland, et al.
Published: (2013-01-01)

Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
by: Claus Aagaard, et al.
Published: (2009-06-01)

Correction: Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
by: Owen Leddy, et al.
Published: (2025-08-01)

A pilot cross-sectional study of non-communicable diseases in TB household contacts
by: Y. Hamada, et al.
Published: (2024-04-01)

The TB27 Transcriptomic Model for Predicting Mycobacterium tuberculosis Culture Conversion
by: Maja Reimann, et al.
Published: (2025-01-01)

Policies, practices, opportunities and challenges for tuberculosis screening: a global survey of national tuberculosis programmes
by: Liana Macpherson, et al.
Published: (2025-07-01)

Search for Mycobacterium avium Subspecies paratuberculosis Antigens for the Diagnosis of Paratuberculosis
by: María Laura Mon, et al.
Published: (2012-01-01)

TB SKIN TEST RESPONSE IN CHILDREN WITH HIV INFECTION
by: N. I. Klevno
Published: (2014-07-01)

Study of Diabetes and Extrapulmonary Tuberculosis (Cervical Lymphoadenopathy, Skin TB, CNS TB, Plueural Tubercular Effusion)
by: Praveen K. Tagore, et al.
Published: (2025-06-01)

Sputum availability and quality in country-level TB prevalence surveys
by: P. Papadopoulou, et al.
Published: (2024-11-01)

Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners.
by: Violet N Chihota, et al.
Published: (2022-01-01)

Sensitivity of the skin test with tuberculous allergen in TB/HIV patients
by: L. V. Poddubnaya, et al.
Published: (2015-11-01)

Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment.
by: James M Young, et al.
Published: (2010-06-01)

Diagnostic Accuracy of <i>Mycobacterium tuberculosis</i> Antigen-Based Skin Tests (TBSTs) for Tuberculosis Infection Compared with TST and IGRA: A Network Meta-Analysis
by: Li Peng, et al.
Published: (2024-11-01)

Direct drug susceptibility testing of Mycobacterium tuberculosis against primary anti-TB drugs in northern India
by: Anamika Gupta, et al.
Published: (2010-06-01)

A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis.
by: Philippe H Lagrange, et al.
Published: (2014-01-01)

Public health benefits of shifting from hospital-focused to ambulatory TB care in Eastern Europe: Optimising TB investments in Belarus, the Republic of Moldova, and Romania.
by: Sherrie L Kelly, et al.
Published: (2023-01-01)

TB or not TB?
by: Andrew Pirotte, et al.
Published: (2024-04-01)

Telluride quantum dot-amplified immunosensor for interferon gamma – A TB antigen test biomarker
by: Sixolile Mini, et al.
Published: (2025-06-01)

The Role of TB-LAMP Method in Detecting Mycobacterium tuberculosis from Sputum of Patients Suspected of Having Pulmonary Tuberculosis
by: Mardiastuti H Wahid, et al.
Published: (2020-12-01)

Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients.
by: Ahmed Esmael, et al.
Published: (2022-01-01)

The Role of TB-LAMP Method in Detecting Mycobacterium tuberculosis from Sputum of Patients Suspected of Having Pulmonary Tuberculosis
by: Mardiastuti H Wahid, et al.
Published: (2020-12-01)

Identification of Cytomegalo Virus Infection Among Mycobacterium Tuberculosis in Baghdad City. Correlation between TB and CMV infection
by: Ali AL-ATTWANI, et al.
Published: (2024-03-01)

Resistance Patterns of Mycobacterium tuberculosis to First-Line Anti-TB Drugs in Kaduna State, North-Western Nigeria
by: Aliyu, M. S., et al.
Published: (2020-06-01)

Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China
by: Peng Lu, et al.
Published: (2025-02-01)

TB elimination in Southern Africa: overview and critical reflection
by: J. Boffa, et al.
Published: (2025-07-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)